Gottlieb thinks "what we're going to have in the fall is hopefully multiple manufacturers that have cleared early-stage safety trials and have millions of doses that could be deployed in large-scale studies inside cities." He says drug companies are planning for such deployments.— Will Saletan (@saletan) May 3, 2020
Gottlieb thinks "what we're going to have in the fall is hopefully multiple manufacturers that have cleared early-stage safety trials and have millions of doses that could be deployed in large-scale studies inside cities." He says drug companies are planning for such deployments.
